No abstract available
MeSH terms
-
Acute Disease
-
Anticoagulants / therapeutic use
-
Cardiovascular Diseases / complications
-
Chronic Disease
-
Fibrinolytic Agents / therapeutic use
-
Humans
-
Hungary
-
Internal Medicine / methods*
-
Mass Screening
-
Neoplasms / complications
-
Nervous System Diseases / complications
-
Platelet Aggregation Inhibitors / therapeutic use
-
Primary Prevention / methods*
-
Risk Assessment
-
Risk Factors
-
Secondary Prevention / methods
-
Surgical Procedures, Operative / adverse effects*
-
Thromboembolism / etiology
-
Thromboembolism / therapy
-
Venous Thromboembolism / drug therapy
-
Venous Thromboembolism / etiology*
-
Venous Thromboembolism / genetics
-
Venous Thromboembolism / prevention & control
-
Venous Thromboembolism / therapy*
-
Vitamin K / antagonists & inhibitors
Substances
-
Anticoagulants
-
Fibrinolytic Agents
-
Platelet Aggregation Inhibitors
-
Vitamin K